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ABSTRACT The mechanism by which mammalian cells
acquire resistance to chemotherapeutic agents has been inves-
tigated by using molecular genetic techniques. LZ and C5, two
independently derived multidrug-resistant Chinese hamster
cell lines, share specific amplified DNA sequences. We dem-
onstrate that commonly amplified DNA sequences reside in a
contiguous domain of :120 kilobases (kb). We report the
isolation of this DNA domain in cosmid clones and show that the
level of amplification of the domain is correlated with the level
of resistance in multidrug-resistant cell lines. The organization
of the amplified domain was deduced by a unique approach
utilizing in-gel hybridization of cloned DNA with amplified
genomic DNA. We show that the entire cloned region is
amplified in adriamycin-resistant LZ cells and independently
derived, colchicine-resistant C5 cells. A mRNA species of '-5
kb is encoded by a gene located within the boundaries of this
region. Genomic sequences homologous to the 5-kb mRNA
span over 75 kb of the amplified DNA segment. The level of
expression of this mRNA in multidrug-resistant cells is corre-
lated with the degree of gene amplification and the degree of
drug resistance. Our results strongly suggest that the 5-kb
mRNA species plays a role in the mechanism of multidrug
resistance common to the LZ and C5 cell lines.
The use of cytotoxic agents in cancer therapy is often
complicated by the emergence of multidrug-resistant tumor
cells. Cultured mammalian cells that exhibit analogous
multidrug-resistance phenotypes present an attractive model
to study this phenomenon (1). It has been suggested that
multidrug resistance is due to a decreased intracellular drug
accumulation (2, 3) caused by alterations of the plasma
membrane (4-6). Multidrug-resistant cells often contain dou-
ble minute chromosomes or homogeneously staining chro-
mosomal regions, suggesting that gene amplification at least
in part underlies multidrug resistance (7-11).
Two independently derived multidrug-resistant Chinese
hamster cell lines, C5 (4) and LZ (11), were used in our
studies. LZ, a highly resistant line, and 77A, a weakly
resistant line, were derived by stepwise selection with in-
creasing concentrations of adriamycin from drug-sensitive
V79 cells (11). C5, a highly colchicine-resistant line, was
derived from drug-sensitive Chinese hamster ovary cells (12).
CS cells are cross-resistant to a number of cytotoxic agents,
including adriamycin and colchicine. In our previous study,
we used the technique of in-gel renaturation (13) to directly
demonstrate the presence of amplified DNA sequences in the
LZ and C5 genomes (14). It was also shown that a subset of
amplified LZ DNA sequences was amplified in common
between the two cell lines. One of the commonly amplified
DNA fragments was cloned, and the degree of its amplifica-
tion in the cells was shown to correlate with the degree of
their drug resistance (14).
In the present study, using phage and cosmid vectors, we
have cloned a contiguous domain of DNA sequences that
spans ==120 kilobases (kb) of the hamster genome and that is
amplified in common in C5 and LZ cells. We have also
developed a method based on in-gel DNA renaturation that
allows the direct assignment of cloned DNA fragments to
their amplified homologs in genomic DNA samples. We have
identified, within the cloned domain, a gene that encodes a
mRNA transcript of -5 kb, whose level of expression
correlates with the degree ofdrug resistance ofV79, 77A, LZ,
and C5 cells. The gene encoding this mRNA is shown to span
at least 75 kb ofDNA within the amplified domain. Our data
also suggest that this gene may be a member of a multigene
family.
MATERIALS AND METHODS
Cell Culture. Chinese hamster cells were grown in minimal
essential medium (GIBCO) lacking nucleosides and supple-
mented with 10% fetal calf serum and L-glutamine (2 mM).
The medium for lines AuxBl and its drug-resistant derivative
CHRC5 (a gift from V. Ling, University of Toronto) was
supplemented with hypoxanthine (0.2 mM) and thymidine
(0.04 mM). The medium for colchicine-resistant C5 cells
contained colchicine (Sigma) at 5 ,g/ml. The V79 cell line
and its adriamycin-resistant derivatives 77A (low level of
resistance), LZ (high level of resistance), and the revertant
LZR (low level of resistance) were provided by N. Howell
(University of Texas). The medium for 77A and LZ cells
contained adriamycin (Adria Laboratories, Columbus, OH)
at 0.1 ,g/ml and 10 ,ug/ml, respectively.
Construction and Screening of Genomic Libraries. Genomic
high molecular weight DNA (15) from LZ cells (100 ,ug) was
partially digested with Sau3A and cloned into the BamHI site
of X EMBL3 vector (16). The library was plated on Esche-
richia coli strain LE392 and duplicate sets of nitrocellulose
filters were screened by plaque-hybridization (17). For clon-
ing in cosmid vectors very high molecular weight DNA (100-
to 200-kb fragment size) (18) was partially digested with Mbo
I and cloned into theBamHI site ofcosmid vector pSAE (19).
Cells of E. coli strain 1046 were transformed to ampicillin
resistance, and duplicate sets of filters were screened by
colony hybridization (20).
In-Gel Renaturation Analysis. Driver and tracer DNAs
were digested with a 5-fold excess of BamHI to assure
complete digestion. Digested and purified tracer DNA was
labeled with 32P to -2 x 107 cpm/,ug with T4 DNA poly-
merase and [a-32P]dCTP ('3000 Ci/mmol; 1 Ci = 37 GBq;
New England Nuclear) (13). In control samples, 15 ,ug of LZ
or V79 driver DNA was mixed with 3 x 106 (Fig. 2a) or 8 x
106 (Fig. 2b) cpm of LZ or V79 tracer DNA, respectively. In
Abbreviation: kb, kilobase(s).
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other samples, 10 ng of cosmid driver DNA was mixed with
3 x 106 cpm (0.2 ,ug) ofeither V79 or LZ tracer DNA and with
10 pug of EcoRI-digested total human DNA (a carrier).
The samples were electrophoresed at 50 V for 36 hr in a
horizontal (30 x 24 x 0.4 cm) gel of 1% agarose in 22.5 mM
Tris acetate, pH 8.3/10 mM sodium acetate/1 mM
Na2EDTA. After electrophoresis the gel was subjected to
two cycles of in-gel renaturation and S1 nuclease digestion as
described (16), with the following modifications: hybridiza-
tion buffer was 50% formamide/5x concentrated SSPE
(SSPE: 10 mM sodium phosphate, pH 7.0/0.18 M NaCl/i
mM Na2EDTA) in Fig. 2a and 50%o formamide/2x concen-
trated SSPE in Fig. 2b. The buffer volume used for washes
was 400 ml per gel, and S1 nuclease digestion was done in 250
ml of digestion buffer containing 40,000 units of S1 nuclease
(Sigma) after five 15-min washes with the digestion buffer.
Following S1 nuclease treatment, the digestion products
were eluted from the gel by washing with 300 ml of SSPE, pH
7.0/0.1% NaDodSO4 for a total of 4 hr with six changes of
buffer. Gels were dried and exposed with Kodak XAR-5 films
at -80°C without screen.
Southern Hybridization. DNA, digested with BamHI and
electrophoresed on 0.8% or 1% agarose gels, was transferred
(21) to a hybridization membrane (Zetabind, Bio-Rad) and
hybridized for 16 hr in 0.75 M NaCl/75 mM sodium citrate,
5x concentrated Denhardt's solution (Denhardt's solution:
0.02% bovine serum albumin/0.02% Ficoll/0.02% polyvinyl-
pyrrolidone), 0.1% NaDodSO4, and 10 1Lg of denatured
salmon sperm DNA per ml to 1-3 x 106 cpm (<10 ng) of the
indicated hybridization probe prepared as described (22).
Blots were washed to a final stringency of 15 mM NaCl/1.5
mM sodium citrate/0.1% NaDodSO4 at 65°C and autoradio-
graphed for 7 hr.
RNA Transfer Blot Hybridization. Total cellular or
poly(A)+ RNA prepared (23) was fractionated on denaturing
(formaldehyde-containing) agarose gels and transferred to a
hybridization membrane (GeneScreenPlus, New England
Nuclear) by electroblotting in 25 mM sodium phosphatebuffer (pH 7.0). DNA-RNA hybridization was carried out for
18 hr at 62°C in the presence of 1 M NaCl, 1% NaDodSO4,
10% dextran sulfate, 10 ,ug of denatured salmon sperm DNA,
and <10 ng ofa 32P-labeled hybridization probe (5 x 106 cpm)(22). Blots were washed to a final stringency of 30 mM NaCl/
3 mM sodium citrate/1% NaDodSO4 at 62°C followed by
autoradiography.
RESULTS
Genomic Cloning and Chromosome Walking Experiments.
DNA isolated from LZ cells was used to construct a library
in X EMBL3 vector. Thirty thousand recombinant phages
were screened with plasmid pDR1.1 (13) as a hybridization
probe. Six clones hybridizing to pDR1.1 were identified and
proved to represent overlapping DNA fragments, each of
which included a 1.1-kb BamHI segment homologous to
pDR1.1. The restriction map of two clones spanning 35 kb of
DNA is presented in Fig. 1 (X DRG2 and X DRZ3). A 7.8-kb
EcoRI fragment was subcloned into pUC18 (24). This single-
copy DNA sequence was used to probe a cosmid library
constructed from LZ DNA in cosmid vector pSAE. Eighteen
positive clones were identified, their restriction maps were
established, and fragments free of repeated sequences were
again isolated and subcloned to yield plasmids pDR9.7 and
pDR2.9. Four successive rounds of screening using "left
side" probes pDR2.9 and pDR2.7 and "right side" probes
pDR9.7, pDR1.6, and pDR2 (see Fig. 1) were performed and
a total of 75 cosmids was isolated. The restriction map of
DNA inserts from these cosmids was determined for BamHI
and Kpn I. The position of seven relevant overlapping
cosmids is shown in Fig. 1 along with the composite BamHI
and Kpn I restriction map of the entire cloned domain. After
five rounds of screening, 120 kb of contiguous chromo-
somal DNA was cloned from adriamycin-resistant LZ cells.
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FIG. 1. Map of amplified domain from multidrug-resistant LZ cells. A composite restriction map of cloned domain for restriction
endonucleases BamHI and Kpn I obtained by analysis of 75 independent clones is presented. The positions of DNA inserts from two
representative phage clones and seven overlapping cosmid clones are indicated. The positions of the repeat-free subclones (pDR2.7 to pDR2)
used in the hybridization analysis are shown as dark boxes along with the restriction enzyme used for cloning.
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Assignment of Cloned Sequences to Fragments of Amplified
DNA from LZ Cells. We proceeded to determine (i) if the
entire cloned region was amplified in LZ DNA and (ii) if the
set of clones in Fig. 1 constituted an accurate representation
of the amplified unit. Our mapping method is based on the
in-gel hybridization procedure (12). Briefly, cloned DNA
fragments from the cosmids (driver DNA) are used to protect
the corresponding 32P-labeled genomic DNA fragments (trac-
er DNA) from digestion with S1 nuclease following electro-
phoresis and in-gel renaturation. Two representative exam-
ples of such gels are shown in Fig. 2 together with BamHI
restriction maps of individual cosmids. In these experiments
10 ng of cosmid DNA digested with BamHI (driver DNA) is
mixed with 32P-labeled tracer DNA (see above) and 10 Ag of
heterologous carrier DNA (human DNA digested with
EcoRI) prior to electrophoresis. When total LZ DNA digest-
ed with BamHI is used both as tracer and driver, the
characteristic pattern of amplified DNA fragments is detect-
ed over the background bands of repetitive DNA present in
the V79/V79 and LZ/LZ lanes (Fig. 2). When BamHI-
digested cosmid DNA is used as driver, protection from
degradation by S1 nuclease ofthe homologous genomic DNA
fragments is observed in LZ but not in V79 DNA lanes (Fig.
2). In experiments of the type shown in Fig. 2 it was possible
to directly assign eight BamHI fragments (present in inde-
pendent cosmids and spanning 65 kb) to the corresponding
set of fragments amplified in LZ cells (LZ tracer/LZ driver
lane). This procedure can thus be used for rapid and accurate
mapping of DNA amplified to 30-50 copies per mammalian
genome.
The above mapping procedure has also facilitated identi-
fication of cosmid clones carrying rearranged insert DNA.
For example, cosmid 1D (Fig. 2a) has five internal BamHI
fragments 16, 8, 7.5, 2, and 1.1 kb long. When used as driver
in combination with LZ tracer DNA, only three of these
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segments (16, 8, and 1.1 kb) protected LZ tracerDNA against
digestion by S1 nuclease. The two other fragments (7.5 and
2 kb) are therefore rearranged and not representative of the
amplified domain in LZ DNA. Another rearranged fragment
was identified in cosmid B2 (Fig. 2b, 8.5-kb fragment) by the
same approach. The correct restriction map of this area was
obtained from cosmid B10, which contains contiguous 13-,
1.3-, and 2.7-kb BamHI fragments, all of which hybridize to
LZ tracer DNA (Fig. 2b).
The mapping approach developed in the present work has
two major advantages over conventional analytical tech-
niques: (i) the presence of highly repeated interspersed DNA
sequences is not an impediment to the analysis; (ii) artefacts
involving rearrangements of the DNA after insertion in the
cloning vector can be readily identified.
It should be noted that a fragment of driver DNA with
partial but continuous homology to a genomic (tracer) frag-
ment of the same electrophoretic mobility can protect the
latter from S1 nuclease digestion. Examples of this phenom-
enon are shown in Fig. 2 (cosmid B10, 16-kb BamHI
fragment; cosmid 1B, 18-kb BamHI fragment).
Characterization of DNA Sequences Coamplified in LZ and
CS Cells. To determine the portions ofthe cloned domain that
are coamplified in relevant multidrug-resistant cell lines, we
performed Southern hybridization with DNA probes isolated
from the LZ amplified domain (Fig. 3). The results show that
the entire cloned region of =120 kb in length is amplified in
C5 and LZ cells since probes pDR2.7, pDR2.9, pDR7.8,
pDR9.7, pDR10, and pDR2 detect DNA fragments amplified
in the LZ and C5 cell lines (Fig. 3). Analyses ofSouthern blots
at different levels of autoradiographic exposure (data not
shown) do not indicate the presence of a so-called "gradient
of amplification" (25) within the -'120-kb amplified domain
analyzed so far in LZ or C5 cells. Each probe in LZ and C5
DNA also detected a second set of weakly cross-hybridizing
b
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FIG. 2. Assignment by in-gel hybridization ofthe cloned BamHI fragments to their homologs amplified in LZ cells. TracerDNA was digested
with BamHL and 32P-labeled with T4 DNA polymerase. Genomic driver DNAs were digested with BamHI (LZ and V79 lanes), whereas cosmid
driver DNAs were digested with either BamHI alone (a) or BamHI together with Sal I (b). For each lane, both tracer and driver DNAs areidentified. The set of BamHI fragments amplified in LZ DNA and contained within the cosmid clones used in this analysis is denoted by
arrowheads. The BamHI restriction map of each of the cosmid insert DNAs used is also shown.
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FIG. 3. Characterization of the amplified domain in LZ and C5 cell lines. Southern hybridization analysis ofBamHI-digested DNA from V79
and Chinese hamster ovary (CHO) AuxBl parental cell lines together with their respective multidrug-resistant derivatives 77A, LZ, LZR, and
C5. In a-f the following 32P-labeled insert DNAs from plasmid subclones overlapping the entire cloned region (Fig. 1) of amplified DNA were
used: pDR2.7 (a), pDR2.9 (b), pDR7.8 (c), pDR9.7 (d), pDR10 (e), pDR2 (f). Amplified DNA fragments that exhibit strong hybridization are
denoted by arrows with the fragment size in kb. DNA fragments that exhibit weak hybridization are denoted by arrowheads.
fragments, identified in Fig. 3 with small arrows (for instance,
in Fig. 3b, pDR2.9 detects a 17-kb fragment, and in Fig. 3e,
pDR10 detects multiple bands). These homologous fragments
follow a pattern of amplification similar to the pattern
observed for the intensely hybridizing DNA bands from cell
lines LZ and C5 (Fig. 4 and data not shown).
Transcription Unit Within the Amplified Domain. To char-
acterize transcriptional products of the amplified DNA re-
gion, RNA prepared from V79, 77A, LZ, and C5 cells was
hybridized by transfer blotting to three subclones of the
cloned DNA (Fig. 5a, pDR7.8; Fig. 5b, pDR1.6; Fig. 5c,
pDR2). All three probes detected a large mRNA species
transcribed to high levels in the two multidrug-resistant cell
lines, C5 and LZ (Fig. 5). Probes mapping to the left of
pDR7.8 and to the right of pDR10 did not hybridize to this
mRNA species (data not shown). Furthermore, the 77A cells
(low level of adriamycin resistance) show a small but signif-
icant increase in this mRNA above the very low background
level of V79 RNA (Fig. 5b). Thus, the region amplified in C5
and LZ cells contains an expressed gene that spans at least
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75 kb and encodes a discrete -5-kb mRNA species whose
intracellular concentration correlates with the relative level
of multidrug resistance of each cell line tested. Since cross-
hybridization between individual cosmids overlapping this
region could not be detected (data not shown), it is most likely
that the amplified region contains a single copy of the gene
encoding this mRNA rather than a cluster of related se-
quences.
DISCUSSION
We demonstrate that molecular cloning techniques and in-gel
renaturation (12, 13) together provide a powerful and general
approach to isolation and characterization of amplified DNA
from eukaryotic cells. By using this approach, -120 kb of
contiguously amplified DNA sequences from LZ cells have
been isolated. We found that a gene that spans at least 75 kb
of this amplified domain encodes a mRNA species of -5 kb,
which is abundant in multidrug-resistant cells but not in their
drug-sensitive parental counterparts. Preliminary experi-
ments using cloned cDNA probes indicate that transcription
of this gene proceeds from a site near the probe pDR7.8
through a site near the probe pDR2 (Fig. 1; unpublished data).
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FIG. 4. Amplification of cross-hybridizing sequences in LZ and
C5 DNA. This is a 5-fold longer exposure (35 hr) ofthe autoradiogram
shown in Fig. 3c.
FIG. 5. Characterization ofDNA sequences transcribed from the
genomic domain amplified in LZ and C5 cells. RNA transfer blot
hybridization analysis of total cellular RNA (b) from V79, 77A, LZ,
and C5 cells and of poly(A)+ RNA (a and c) from V79 and LZ cells.
Twenty micrograms of total cellular RNA (b) or 1 jig of poly(A)4
RNA (a and c) was electrophoresed. Blots were hybridized to
32P-labeled insert DNAs from plasmids pDR7.8 (a), pDR1.6 (b), and
pDR2 (c).
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The 5-kb mRNA species is likely to play a role in the
multidrug-resistant phenotype. The nature of protein(s) en-
coded by this mRNA and the mechanism of multidrug
resistance remain unknown. Ling and co-workers (26, 27)
have established a correlation in various cell lines between
the degree of colchicine resistance and the increased expres-
sion of a 170-kDa membrane glycoprotein, gp170. The length
of the mRNA species identified in the present work (-5 kb)
is consistent with it encoding a polypeptide of 170 kDa in size.
Furthermore, LZ and 77A cells express levels of gpl70
proportional to their respective levels of resistance to
adriamycin (unpublished data). On the other hand, Kuo et al.
(9) have identified a 21-kDa polypeptide that is expressed at
high levels in vincristine-resistant hamster cells. Biedler et al.
have also described a 19-kDa cytosolic protein overex-
pressed in vincristine-resistant hamster cells (28). Loss of
specific 75-kDa and 72-kDa glycoproteins has also been
observed in multidrug-resistant cells (29). mRNA and
genomic DNA sequences encoding these proteins remain to
be identified.
Even though amplification and corresponding overexpres-
sion of the gene encoding the 5-kb mRNA are the most likely
candidates for a common mechanism of multidrug resistance,
other genes may also be involved in the establishment of
resistance to a particular cytotoxic agent, in particular,
because multidrug-resistant cell lines usually show the high-
est level of relative drug resistance to the agent used in the
original selection process.
In addition to the major set of amplified DNA sequences in
LZ DNA, Southern hybridization analyses detected also
weakly cross-hybridizing DNA sequences distinct from those
in the major set (see Figs. 3 and 4). One interpretation of this
result is that the gene present within the amplified domain is
a member of a multigene family. A second possibility is that
the above minor fragments are the result ofDNA rearrange-
ments that have occurred during DNA amplification in LZ
cells. Such rearranged DNA sequences have been described
in studies of several other amplified genes (30-32). The fact
that some ofthe cross-hybridizing sequences can be detected
in the genome ofthe parental V79 and Chinese hamster ovary
AuxB1 cell lines (Fig. 4, 2.1-kb BamHI fragment) argues
against this second possibility. Furthermore, preliminary
experiments involving cDNA cloning are consistent with the
first possibility: we have identified at least two distinct cDNA
populations homologous to DNA sequences from the ampli-
fied genomic domain (unpublished data).
Our results strongly suggest that the common mechanism
of multidrug resistance in the independently derived LZ and
CS cells involves overexpression of the 5-kb mRNA encoded
within the amplified domain. Whether the phenotype of
multidrug resistance is due to overexpression ofthe unaltered
endogenous copy of the gene or whether alterations in the
initial nucleotide sequence (followed by its overexpression)
are also essential remains to be determined. Cloned DNA
fragments from the genomic domain amplified in the two
multidrug-resistant cell lines represent valuable tools to study
multidrug resistance in other systems, including human
tumors that have developed drug resistance in the course of
chemotherapy.
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